We hypothesized that colchicine could have a great impact on obesity and MS due to its anti-inflammatory effects, especially in the NLRP3 inflammasome, a key component of chronic inflammation in obese patients [20,21]. The gene discussed is NLRP3; the disease is myeloid sarcoma.